Brown Advisory’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.74M Sell
19,201
-2,126
-10% -$195K ﹤0.01% 707
2025
Q4
$1.92M Sell
21,327
-1,810
-8% -$172K ﹤0.01% 688
2025
Q3
$2.28M Sell
23,137
-581
-2% -$57.6K ﹤0.01% 644
2025
Q2
$2.16M Buy
23,718
+10,542
+80% +$1.02M ﹤0.01% 644
2025
Q1
$1.49M Sell
13,176
-949
-7% -$102K ﹤0.01% 688
2024
Q4
$1.49M Sell
14,125
-331
-2% -$35.5K ﹤0.01% 718
2024
Q3
$1.56M Sell
14,456
-206
-1% -$22.5K ﹤0.01% 689
2024
Q2
$1.59M Sell
14,662
-646
-4% -$76.2K ﹤0.01% 672
2024
Q1
$2.02M Sell
15,308
-1,491
-9% -$186K ﹤0.01% 636
2023
Q4
$2.04M Buy
16,799
+396
+2% +$44.2K ﹤0.01% 621
2023
Q3
$1.84M Buy
16,403
+986
+6% +$125K ﹤0.01% 625
2023
Q2
$2.24M Sell
15,417
-131
-0.8% -$17.8K ﹤0.01% 592
2023
Q1
$2.01M Sell
15,548
-36
-0.2% -$4.52K ﹤0.01% 610
2022
Q4
$1.99M Buy
15,584
+1,542
+11% +$179K ﹤0.01% 614
2022
Q3
$1.47M Buy
14,042
+356
+3% +$39.1K ﹤0.01% 631
2022
Q2
$1.44M Sell
13,686
-282
-2% -$33.5K ﹤0.01% 631
2022
Q1
$1.79M Buy
13,968
+773
+6% +$93.2K ﹤0.01% 605
2021
Q4
$1.63M Buy
13,195
+654
+5% +$85.6K ﹤0.01% 635
2021
Q3
$1.78M Sell
12,541
-794
-6% -$117K ﹤0.01% 590
2021
Q2
$2.08M Buy
13,335
+159
+1% +$25.8K ﹤0.01% 567
2021
Q1
$2.05M Sell
13,176
-378
-3% -$58.6K ﹤0.01% 592
2020
Q4
$2.03M Sell
13,554
-2,158
-14% -$305K ﹤0.01% 540
2020
Q3
$2.08M Sell
15,712
-1,516
-9% -$198K ﹤0.01% 513
2020
Q2
$2M Sell
17,228
-464
-3% -$53.5K ﹤0.01% 505
2020
Q1
$1.74M Sell
17,692
-2,610
-13% -$342K 0.01% 493
2019
Q4
$2.95M Buy
20,302
+1,776
+10% +$245K 0.01% 480
2019
Q3
$2.47M Buy
18,526
+233
+1% +$30.1K 0.01% 488
2019
Q2
$2.09M Sell
18,293
-23,722
-56% -$2.78M 0.01% 515
2019
Q1
$5.21M Buy
42,015
+731
+2% +$83.1K 0.01% 447
2018
Q4
$4.16M Sell
41,284
-3,979
-9% -$447K 0.01% 446
2018
Q3
$5.78M Buy
45,263
+4,007
+10% +$476K 0.02% 420
2018
Q2
$4.46M Buy
41,256
+24,756
+150% +$2.69M 0.01% 461
2018
Q1
$1.75M Buy
16,500
+2,072
+14% +$241K 0.01% 545
2017
Q4
$1.69M Sell
14,428
-22
-0.2% -$2.49K 0.01% 560
2017
Q3
$1.64M Sell
14,450
-560
-4% -$64.6K 0.01% 550
2017
Q2
$1.87M Sell
15,010
-716
-5% -$84.9K 0.01% 551
2017
Q1
$1.86M Sell
15,726
-102
-0.6% -$11.6K 0.01% 524
2016
Q4
$1.59M Sell
15,828
-526
-3% -$56.4K 0.01% 536
2016
Q3
$2.06M Buy
16,354
+194
+1% +$24K 0.01% 498
2016
Q2
$1.89M Buy
16,160
+479
+3% +$54.2K 0.01% 499
2016
Q1
$1.62M Sell
15,681
-2,060
-12% -$199K 0.01% 503
2015
Q4
$1.77M Buy
17,741
+1,655
+10% +$162K 0.01% 484
2015
Q3
$1.47M Buy
16,086
+5,467
+51% +$548K 0.01% 516
2015
Q2
$1.13M Sell
10,619
-2,140
-17% -$237K ﹤0.01% 507
2015
Q1
$1.46M Buy
12,759
+1,373
+12% +$157K ﹤0.01% 500
2014
Q4
$1.25M Sell
11,386
-254
-2% -$26.8K ﹤0.01% 518
2014
Q3
$1.14M Sell
11,640
-635
-5% -$62.5K ﹤0.01% 525
2014
Q2
$1.24M Sell
12,275
-490
-4% -$47.8K ﹤0.01% 521
2014
Q1
$1.17M Buy
12,765
+577
+5% +$53.2K ﹤0.01% 513
2013
Q4
$1.1M Buy
12,188
+1,453
+14% +$126K ﹤0.01% 513
2013
Q3
$856K Sell
10,735
-824
-7% -$64.9K ﹤0.01% 530
2013
Q2
$842K Buy
+11,559
New +$864K ﹤0.01% 501

Other funds holding ZBH

Brown Advisory's ZBH Position: Q1 2026 in Review

Brown Advisory reduced its Zimmer Biomet (ZBH) stake by 10% in Q1 2026, selling an estimated $195K and leaving 19,201 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #707.

Brown Advisory first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.78M in Q3 2018. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Brown Advisory held 19,201 shares of Zimmer Biomet worth $1.74M as of Q1 2026.
  • Brown Advisory sold 2,126 Zimmer Biomet shares in Q1 2026, an estimated $195K.
  • Zimmer Biomet made up ﹤0.01% of Brown Advisory's portfolio in Q1 2026, its #707 holding.
  • Brown Advisory first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Brown Advisory's Zimmer Biomet position peaked at $5.78M in Q3 2018.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.